Mori Ana Luiza Pereira Moreira, Carvalho Renata Cunha, Aguiar Patricia Melo, de Lima Maria Goretti Farias, Rossi Magali da Silva Pacheco Nobre, Carrillo José Fernando Salvador, Dórea Egídio Lima, Storpirtis Sílvia
Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
University Hospital, University of São Paulo, São Paulo, Brazil.
Int J Clin Pharm. 2017 Apr;39(2):386-393. doi: 10.1007/s11096-017-0433-7. Epub 2017 Feb 10.
Background The Screening Tool of Older Persons' Prescriptions/Screening Tool to Alert doctors to Right Treatment (STOPP/START) criteria is used to identify instances of potentially inappropriate prescribing in a patient's medication regimen. Objective To determine the prevalence and predictors of potentially inappropriate medications (PIMs) and potential prescribing omissions (PPOs) among elderly patients at hospital discharge. Setting A university hospital medical clinic in Brazil. Method Discharge prescriptions were examined using the STOPP/START criteria. Subjects were inpatients aged ≥60 years receiving at least one medication prior to hospitalization and with a history of cardiovascular disease. The prevalence of PIMs and PPOs was determined and a multivariable binary regression analysis was performed to identify independent predictors associated with PIMs or PPOs. Main outcome measure Prevalence of PIMs and PPOs. Results Of the 230 subjects, 13.9% were prescribed at least one PIM. The most frequently prescribed PIMs were glibenclamide or chlorpropamide prescribed for type 2 diabetes mellitus (31.0%), and aspirin at doses >150 mg/day (14.3%). Ninety patients had at least one PPO (39.1%). The most prevalent PPOs were statins (29.8%) and antiplatelet therapy (13.7%) for diabetes mellitus when coexisting major cardiovascular risk factors were present. No predictors for PIMs were found. In contrast, diabetes was a risk factor while dyslipidaemia was a protective factor for PPOs. Conclusion PIMs and PPOs commonly occur with elderly people at hospital discharge. Diabetes and dyslipidaemia were significantly associated with PPOs. Our findings show the need for interventions to reduce potentially inappropriate prescribing, such as a pharmacist medication review process at hospital discharge.
老年人处方筛查工具/提醒医生正确治疗的筛查工具(STOPP/START)标准用于识别患者药物治疗方案中潜在不适当处方的情况。目的:确定老年患者出院时潜在不适当药物(PIM)和潜在处方遗漏(PPO)的患病率及预测因素。地点:巴西一家大学医院的医疗诊所。方法:使用STOPP/START标准检查出院处方。研究对象为年龄≥60岁、住院前至少服用一种药物且有心血管疾病史的住院患者。确定PIM和PPO的患病率,并进行多变量二元回归分析以识别与PIM或PPO相关的独立预测因素。主要结局指标:PIM和PPO的患病率。结果:在230名研究对象中,13.9%的患者至少被开具了一种PIM。最常开具的PIM是用于2型糖尿病的格列本脲或氯磺丙脲(31.0%),以及剂量>150mg/天的阿司匹林(14.3%)。90名患者至少有一项PPO(39.1%)。最常见的PPO是在存在主要心血管危险因素时用于糖尿病的他汀类药物(29.8%)和抗血小板治疗(13.7%)。未发现PIM的预测因素。相比之下,糖尿病是PPO的危险因素,而血脂异常是PPO的保护因素。结论:PIM和PPO在老年患者出院时普遍存在。糖尿病和血脂异常与PPO显著相关。我们的研究结果表明需要采取干预措施以减少潜在不适当处方,如出院时由药剂师进行药物审查。